119 related articles for article (PubMed ID: 37211172)
1. STING activation in macrophages by vanillic acid exhibits antineoplastic potential.
Zhu M; Tang X; Zhu Z; Gong Z; Tang W; Hu Y; Cheng C; Wang H; Sarwar A; Chen Y; Liu F; Huo J; Wang X; Zhang Y
Biochem Pharmacol; 2023 Jul; 213():115618. PubMed ID: 37211172
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site.
Ohkuri T; Kosaka A; Ishibashi K; Kumai T; Hirata Y; Ohara K; Nagato T; Oikawa K; Aoki N; Harabuchi Y; Celis E; Kobayashi H
Cancer Immunol Immunother; 2017 Jun; 66(6):705-716. PubMed ID: 28243692
[TBL] [Abstract][Full Text] [Related]
3. SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma.
Li Y; Gao Y; Jiang X; Cheng Y; Zhang J; Xu L; Liu X; Huang Z; Xie C; Gong Y
J Transl Med; 2022 Dec; 20(1):628. PubMed ID: 36578072
[TBL] [Abstract][Full Text] [Related]
4. Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells.
Miao L; Qi J; Zhao Q; Wu QN; Wei DL; Wei XL; Liu J; Chen J; Zeng ZL; Ju HQ; Luo HY; Xu RH
Theranostics; 2020; 10(2):498-515. PubMed ID: 31903134
[No Abstract] [Full Text] [Related]
5. XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression.
Wang Q; Bu Q; Liu M; Zhang R; Gu J; Li L; Zhou J; Liang Y; Su W; Liu Z; Wang M; Lian Z; Lu L; Zhou H
JHEP Rep; 2022 Nov; 4(11):100555. PubMed ID: 36185574
[TBL] [Abstract][Full Text] [Related]
6. STING agonist diABZI induces PANoptosis and DNA mediated acute respiratory distress syndrome (ARDS).
Messaoud-Nacer Y; Culerier E; Rose S; Maillet I; Rouxel N; Briault S; Ryffel B; Quesniaux VFJ; Togbe D
Cell Death Dis; 2022 Mar; 13(3):269. PubMed ID: 35338116
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of Phagocytosis Checkpoint Silencer and Stimulator of Interferon Genes Agonist for Synergetic Cancer Immunotherapy.
Lu ZD; Chen YF; Shen S; Xu CF; Wang J
ACS Appl Mater Interfaces; 2021 Jun; 13(25):29424-29438. PubMed ID: 34129318
[TBL] [Abstract][Full Text] [Related]
8. Targeting macrophage priming by polyphyllin VII triggers anti-tumor immunity via STING-governed cytotoxic T-cell infiltration in lung cancer.
Yu J; Deng H; Xu Z
Sci Rep; 2020 Dec; 10(1):21360. PubMed ID: 33288772
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Integrative Analysis Reveals the Association of
Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
[TBL] [Abstract][Full Text] [Related]
10. Effects of STING stimulation on macrophages: STING agonists polarize into "classically" or "alternatively" activated macrophages?
Ohkuri T; Kosaka A; Nagato T; Kobayashi H
Hum Vaccin Immunother; 2018 Feb; 14(2):285-287. PubMed ID: 29064738
[TBL] [Abstract][Full Text] [Related]
11. Macrophage STING signaling promotes NK cell to suppress colorectal cancer liver metastasis via 4-1BBL/4-1BB co-stimulation.
Sun Y; Hu H; Liu Z; Xu J; Gao Y; Zhan X; Zhou S; Zhong W; Wu D; Wang P; Rao Z; Kong L; Zhou H
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36927529
[TBL] [Abstract][Full Text] [Related]
12. Apigenin Suppresses Innate Immune Responses and Ameliorates Lipopolysaccharide-Induced Inflammation via Inhibition of STING/IRF3 Pathway.
Zhou XW; Wang J; Tan WF
Am J Chin Med; 2024; 52(2):471-492. PubMed ID: 38480499
[TBL] [Abstract][Full Text] [Related]
13. STING/TBK1 Regulates Inflammation in Macrophages and Titanium Particles-Induced Osteolysis.
Ouyang Z; Xu J; Liu T; Lin S; Sun Y; Huang Y; Zheng Z; Zeng G; Li C; Li S; Ding Y
ACS Biomater Sci Eng; 2023 Jun; 9(6):3273-3284. PubMed ID: 37134278
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Effects of Azithromycin and STING Agonist Promote IFN-I Production by Enhancing the Activation of STING-TBK1 Signaling.
Petcharat K; Munkong N; Thongboontho R; Chartarrayawadee W; Thim-Uam A
J Exp Pharmacol; 2023; 15():407-421. PubMed ID: 37933302
[TBL] [Abstract][Full Text] [Related]
15. Primary Tumor Suppression and Systemic Immune Activation of Macrophages through the Sting Pathway in Metastatic Skin Tumor.
Synn CB; Kim DK; Kim JH; Byeon Y; Kim YS; Yun MR; Lee JM; Lee W; Lee EJ; Lee S; Lee YW; Lee DJ; Kim HW; Kim CG; Hong MH; Park JD; Lim SM; Pyo KH
Yonsei Med J; 2022 Jan; 63(1):42-55. PubMed ID: 34913283
[TBL] [Abstract][Full Text] [Related]
16. Traditional Chinese medicine Lingguizhugan decoction ameliorate HFD-induced hepatic-lipid deposition in mice by inhibiting STING-mediated inflammation in macrophages.
Cao L; Xu E; Zheng R; Zhangchen Z; Zhong R; Huang F; Ye J; Sun H; Fan Y; Xie S; Chen Y; Xu Y; Cao J; Cao W; Liu C
Chin Med; 2022 Jan; 17(1):7. PubMed ID: 34983596
[TBL] [Abstract][Full Text] [Related]
17. Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer.
Shakfa N; Li D; Conseil G; Lightbody ED; Wilson-Sanchez J; Hamade A; Chenard S; Jawa NA; Laight BJ; Afriyie-Asante A; Tyryshkin K; Koebel M; Koti M
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37015760
[TBL] [Abstract][Full Text] [Related]
18. Enhancing anti-tumor immunity through liposomal oxaliplatin and localized immunotherapy via STING activation.
Gu Z; Hao Y; Schomann T; Ossendorp F; Ten Dijke P; Cruz LJ
J Control Release; 2023 May; 357():531-544. PubMed ID: 37030544
[TBL] [Abstract][Full Text] [Related]
19. STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer.
Wang Q; Bergholz JS; Ding L; Lin Z; Kabraji SK; Hughes ME; He X; Xie S; Jiang T; Wang W; Zoeller JJ; Kim HJ; Roberts TM; Konstantinopoulos PA; Matulonis UA; Dillon DA; Winer EP; Lin NU; Zhao JJ
Nat Commun; 2022 May; 13(1):3022. PubMed ID: 35641483
[TBL] [Abstract][Full Text] [Related]
20. Blockade of the Phagocytic Receptor MerTK on Tumor-Associated Macrophages Enhances P2X7R-Dependent STING Activation by Tumor-Derived cGAMP.
Zhou Y; Fei M; Zhang G; Liang WC; Lin W; Wu Y; Piskol R; Ridgway J; McNamara E; Huang H; Zhang J; Oh J; Patel JM; Jakubiak D; Lau J; Blackwood B; Bravo DD; Shi Y; Wang J; Hu HM; Lee WP; Jesudason R; Sangaraju D; Modrusan Z; Anderson KR; Warming S; Roose-Girma M; Yan M
Immunity; 2020 Feb; 52(2):357-373.e9. PubMed ID: 32049051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
